PTEN and cancer: Lipid phosphatases act as negative regulators of PI3K signaling, with the phosphatase and tensin homolog (PTEN) protein being the most prominent member, frequently mutated or deleted across various human cancers, leading to constitutive activation of the PI3K/Akt pathway [94,95].